Skip to main content
. 2021 Dec 21;14:459–474. doi: 10.2147/IJNRD.S342099

Table 1.

Baseline Demographic and Clinical Characteristics of Hypertension Patients Included in the Study

Variable Total (n = 304) No CKD (n = 213) CKD (n = 91) P-value*
Median age-Median, IQR 55 (48–63) 55 (46–62) 60 (50–65) 0.02
Age category (years)-n,% 0.07#
 18–29 5 (1.6) 5 (2.3) 0 (0.0)
 30–39 21 (6.9) 17 (8.0) 4 (4.4)
 40–49 63 (20.7) 45 (21.1) 18 (19.8)
 50–59 92 (30.3) 70 (32.9) 22 (24.2)
 60 and above 123 (40.5) 76 (35.7) 47 (51.6)
 Age less than 60 181 (59.5) 137 (64.3) 44 (48.3) 0.009
 Age over 60 123 (40.5) 76 (35.7) 47 (51.7)
Gender- n,%
 Male 97 (31.9) 76 (35.7) 21 (23.1) 0.03
 Female 207 (68.1) 137 (64.3) 70 (76.9)
Educational level-n,%
 Never educated 165 (54.3) 102 (47.9) 63 (69.2) 0.001
 Some education 139 (45.7) 111 (52.1) 28 (30.8)
Occupation-n,%
 None 114 (37.5) 75 (35.2) 39 (42.9) 0.3
 Employed 132 (43.4) 93 (43.7) 39 (42.9)
 Farmer 55 (18.1) 42 (19.7) 13 (14.2)
 Missing 3 (1.0%) 3 (1.4) 0 (0.0)
Marital status-n,%
 Not married 102 (33.6) 67 (31.5) 35 (38.5) 0.24
 Married/cohabiting 202 (66.4) 146 (68.5) 56 (61.5)
Years since hypertension diagnosis-n,%
 0–2years 169 (55.6) 124 (58.2) 45 (49.4) 0.16
 Over 2 years 135 (44.4) 89 (41.8) 46 (50.6)
Duration in the clinic (Months)-n,%
 Less than 12 months 170 (55.9) 129 (60.6) 41 (45.1) 0.02
 More than 12 months 132 (43.4) 84 (39.4) 48 (52.7)
 Missing 2 (0.7) 0 (0.0) 2 (2.2)
Family history of hypertension-n,%
 No 81 (26.6) 59 (27.7) 22 (24.2) 0.81
 Yes 147 (48.4) 101 (47.4) 46 (50.5)
 Do not Know 76 (25.0) 53 (24.9) 23 (25.3)
Family history CKD-n,%
 No 161 (53.0) 110 (51.6) 51 (56.0) 0.36#
 Yes 9 (3.0) 5 (2.4) 4 (4.4)
 Do not Know 134 (44.0) 98 (46.0) 36 (39.6)
History of smoking-n,%
 No 199 (65.5) 137 (64.3) 62 (68.1) 0.52
 Yes 105 (34.5) 76 (35.7) 29 (31.9)
History of alcohol intake-n,%
 No 205 (67.4) 140 (65.7) 65 (71.4) 0.33
 Yes 99 (32.6) 73 (34.3) 26 (28.6)
History of Diabetes-n,%
 No 270 (88.8) 191 (89.7) 79 (86.8) 0.47
 Yes 34 (11.2) 22 (10.3) 12 (13.2)
History of heart failure-n,%
 No 295 (97.1) 207 (97.2) 88 (96.7) 0.79#
 Yes 8 (2.6) 5 (2.3) 3 (3.3)
 Do not Know 1 (0.30) 1 (0.5) 0 (0.0)
Living with HIV-n,%
 No 299 (98.4) 211 (99.1) 88 (96.7) 0.16#
 Yes 5 (1.6) 2 (0.9) 3 (3.3)
History of previous stroke-n,%
 No 281 (92.4) 196 (92.0) 85 (93.4) 0.66
 Yes 23 (7.6) 17 (8.0) 6 (6.6)
Intake of non-prescribed medication for hypertension –n,%
 No 250 (82.2) 175 (82.4) 75 (82.4) 0.96
 Yes 54 (17.8) 38 (17.6) 16 (17.6)
Past Intake of herbal medications for hypertension-n,%
 No 247 (81.2) 174 (81.7) 73 (80.2) 0.76
 Yes 57 (18.8) 39 (18.3) 18 (19.8)
Current Intake of herbal medications for hypertension -n,%
 No 293 (96.4) 209 (98.1) 84 (92.3) 0.02#
 Yes 11 (3.6) 4 (1.9) 7 (7.7)
Use of non-steroidal anti-inflammatory drugs -n,%
 No 145 (47.7) 97 (45.5) 48 (52.7) 0.18
 Yes 100 (32.9) 77 (36.2) 23 (25.3)
 Do not Know 59 (19.4) 39 (18.3) 20 (22.0)
Normally add salt before eating-n,%
 Never 79 (26.0) 53 (24.9) 26 (28.6) 0.5
 Eat salt 225 (74.0) 160 (75.1) 65 (71.4)
Current number of anti-hypertensive drugs –n,%
 1 20 (6.6) 12 (5.6) 8 (8.9) 0.52
 2 201 (66.1) 144 (67.6) 57 (62.6)
 3 or more 82 (27.0) 56 (26.3) 26 (28.5)
 Missing 1 (0.3) 1 (0.5) 0 (0.0)
Current use of ACE Inhibitors-n,%
 No 199 (65.5) 141 (66.2) 58 (63.7) 0.68
 Yes 105 (34.5) 72 (33.8) 33 (36.3)
Currently taking NSAIDs-n,%
 No 261 (85.9) 182 (85.4) 79 (86.8) 0.75
 Yes 43 (14.1) 31 (14.6) 12 (13.2)
Median BMI (kg/m2)-median, IQR 26.2 (22.4–30.5) 25.7 (21.9–30.1) 28.0 (24.0–31.0) 0.008c
BMI category (kg/m2)-n,%
 Underweight (below 18.5 kg/m2) 9 (3.0) 7 (3.3) 2 (2.2) 0.02#
 Normal (18.5-<25 kg/m2) 114 (37.5) 91 (42.7) 23 (25.3)
 Overweight (25.0-<30 kg/m2) 88 (28.9) 54 (25.4) 34 (37.4)
 Obesity (30.0 kg/m2 and above) 85 (28.0) 56 (26.3 29 (31.9)
 Missing 8 (2.6) 5 (2.3) 3 (3.2)
Most recent systolic blood pressure (mmHg)-Median, IQR 158 (143–177) 158 (143–177) 158 (143–177) 0.78c
Most recent diastolic blood pressure (mmHg)-Median, IQR 99 (92–109) 99 (93–109) 98 (90–109) 0.22c
Most recent blood glucose (mg/dl)-Median, IQR 5.7 (4.9–7.2) 5.7 (4.9–7.2) 5.4 (4.8–6.8) 0.21c
Hypertension grade-n,%
 Normal (<140 and <90 mmHg) 39 (12.8) 26 (12.2) 13 (14.3) 0.88
 Grade 1 (140–159 and/or 90–99 mmHg) 82 (27.0) 57 (26.8) 25 (27.4)
 Grade 2 (160–179 and/or 100–109 mmHg) 79 (26.0) 58 (27.2) 21 (23.1)
 Grade 3 (≥180 and/or ≥110 mmHg) 104 (34.2) 72 (33.8) 32 (35.2)

Notes: *Chi2 tests unless otherwise stated #Fishers exact test, cWilcoxon rank-sum test. Bold P-value less than 0.05.

Abbreviations: CKD, chronic kidney disease; IQR, interquartile range; %, percentage; NSAIDs, non-steroidal anti-inflammatory drugs; n, number; BMI, body mass index; ACE, angiotensin converting enzyme.